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M H SanadAbstract
Background: Histamine was successfully labeled with technetium-99 m (99mTc). The studied reaction parameters
included substrate concentration, reducing agent concentration, pH of the reaction mixture, reaction time, in vitro
stability of the 99mTc-histamine, and biodistribution in experimental animals.
Method: Accurately weighed 3 mg histamine was dissolved and transferred to an evacuated penicillin vial. Exactly
50 μg SnCl2 dihydrate was added and the pH of the mixture was adjusted to 4 using 0.1N HCl, then the volume of
the mixture was adjusted to one ml by N2-purged distilled water. One ml of freshly eluted
99mTcO4- (~ 400MBq)
was added to the above mixture. The reaction mixture was vigorously shaken and allowed to react at room
temperature for sufficient time to complete the reaction
Result: The complex gives a maximum labeling yield of 98.0% ± 0.34%, and maintained stability throughout the
working period (6 h). Biodistribution investigation showed that the maximum uptake of the 99mTc-histamine in the
brain was 7.1% ± 0.12% of the injected activity/g tissue organ, at 5 min post-injection. The clearance from the mice
appeared to proceed via the circulation mainly through the kidneys and urine (approximately 37.8% of the injected
dose at 2 h after injection of the tracer).
Conclusions: Brain uptake of 99mTc-histamine is higher than that of (99mTc-ECD and 99mTc-HMPAO) therefore
99mTc-histamine could be used for brain single-photon emission computed tomography (SPECT). Furthermore,
99mTc-histamine could be considered as a novel radiopharmaceutical for brain imaging.
Keywords: Histamine; Hexamethylpropyleneamine oxime and ethyl cysteinate dimer; Technetium-99 m; Labeling;
Biodistribution; Brain; ImagingBackground
Several recent reviews describe the use of single-photon
emission computed tomography (SPECT) alone or in com-
bination with PET and/or functional magnetic resonance
imaging (fMRI) in studies of human cognition, imaging of
neuroreceptor systems, aiding diagnosis or assessment of
progression or treatment response in various psychiatric
and neurologic disorders, neuropharmacologic challenge
studies and in the new field of molecular imaging, includ-
ing imaging of transgene expression (Devous 2002;
Catafau 2001; Mazziotta and Toga 2002; Lee and
Newberg 2005; Bonte and Devous 2003; Devous Sr 1998;Correspondence: msanad74@yahoo.com
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in any medium, provided the original work is pBrooks 2005; Heinz et al. 2000; Dickerson and Sperling
2005; Bammer et al. 2005; Eckert and Eidelberg 2005;
Kuzniecky 2005). Brain SPECT is now commonly used in
the diagnosis, prognosis assessment, evaluation of res-
ponse to therapy, risk stratification, detection of benign or
malignant viable tissue, and choice of medical or surgical
therapy, especially in head injury, malignant brain tumors,
cerebrovascular disease, movement disorders, dementia,
and epilepsy (Lee and Newberg 2005; Bonte and Devous
2003; Devous Sr 1998; Brooks 2005; Heinz et al. 2000;
Dickerson and Sperling 2005; Bammer et al. 2005; and
Kuzniecky 2005). The selection of the proper isotope to
be used in labeling and in imaging is important because it
should have a suitable short half-life to avoid unwarranted
harmful exposure to radiation and suitable photon energyn Access article distributed under the terms of the Creative Commons




















Figure 1 The chemical structure of histamine (a), proposed
structure of the 99mTc-histamine (b).
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isotopes that fulfill these two precautions are 123I and 99mTc.
Brain imaging in humans is currently achieved by using
99mTc-ethyl cysteinate dimer (99mTc-ECD), 99mTc-hexam-
ethylpropyleneamine oxime (99mTc-HMPAO), 125I-sibutra-
mine, and 125I-fluoxetine (Ogasawara et al. 2001; Chang
et al. 2002; Bonte et al. 2010; and El-Ghany et al. 2007).
The major disadvantage of these compounds is their poor
brain uptake in experimental animals (4.7% for 99mTc-ECD
and 2.25% for 99mTc-HMPAO) (Walovitch et al. 1989;
Neirinckx et al. 1987). Such low uptake enforces us to try
to find novel radiopharmaceuticals that can overcome this
limitation and can be used as more efficient brain imaging
agents. Histamine [2-(1H-imidazol-4-yl)] ethanamine is an
organic nitrogen compound involved in local immune re-
sponses as well as regulating physiological function in the
gut and acting as a neurotransmitter (Marieb 2001). Hista-
mine increases the permeability of the capillaries to white
blood cells and some proteins to allow them to engage path-
ogens in the infected tissues (Di Giuseppe et al. 2003). Hista-
mine is known to be involved in so many physiological
functions because of its chemical properties that allow it to
be so versatile in binding (Noszal et al. 2004). In this paper,
histamine was labeled with the most widely used imaging
radionuclide, 99mTc. Factors affecting the labeling yield of
99mTc-histamine complex and biological distribution in Swiss
Albino mice (25 to 30 g) were studied in detail (Motaleb and
Sanad 2012). The radiochemical yield of the product was de-
termined by paper chromatography, paper electrophoresis,
and high-performance liquid chromatography (HPLC).
Methods
Drugs and chemicals
Histamine was purchased from Sigma-Aldrich Chemical
Company, St. Louis, MO, USA, and all other chemicals
were purchased from Merck (Whitehouse Station, NJ,
USA) and they were reactive grade. The water used is
purged deoxygenated bidistilled water.
Labeling of histamine
Accurately weighed 3 mg histamine was dissolved and
transferred to an evacuated penicillin vial. Exactly 50 μg
SnCl2 dihydrate was added and the pH of the mixture was
adjusted to 4 using 0.1 N HCl, then the volume of the mix-
ture was adjusted to 1 ml by N2-purged distilled water. One
milliliter of freshly eluted 99mTcO4
− (approximately
400 MBq) was added to the above mixture. The reaction
mixture was vigorously shaken and allowed to react at room
temperature for sufficient time to complete the reaction
(Boyd 1986). The proposed structure of the 99mTc-histamine
via reaction of histamine with 99mTcO4
− in the presence of
stannous chloride dihydrate at pH 4 at room temperature is
shown in Figure 1b, where the oxidation state of 99mTc
changed from +7 into +5 to form a complex with twomolecules of histamine. 99mTc-histamine complex coordi-
nated as a Tc (V) oxocore, leading to complexes in which a
TcO3+ core exists (Jurisson et al. 1986; Abrams et al. 1991).
Factors affecting % labeling yield
This experiment was conducted to study the different factors
that affect labeling yield such as tin content as (SnCl2 ·
2H2O), substrate content, pH of the reaction, and reaction
time. In the process of labeling, trials and errors were per-
formed for each factor under investigations till obtains the
optimum value. The experiment was repeated with all factors
kept at optimum changing except the factor under study, till
the optimal conditions are achieved (Robbins 1984).
Quality control
Paper chromatography
Radiochemical yield of 99mTc-histamine was checked by
paper chromatography method in which, the reaction
product was spotted on ascending paper chromatogra-
phy strips (10 × 1.5 cm). Free 99mTcO4
− in the preparation
was determined using acetone as the mobile phase. Re-
duced hydrolyzed technetium was determined by using an
ethanol/water/ammonium hydroxide mixture (2:5:1) or
5 N NaOH as the mobile phase. After complete develop-
ment, the strips were dried then cut into 0.5-cm pieces
and counted in a well-type γ-scintillation counter.
HPLC analysis
An HPLC analysis of histamine solution was done by an in-
jection of 10 μl from the reaction mixture into the column
(RP-18-250 × 4.6 mm2, 5 μm, Lischrosorb) built in an HPLC
Shimadzu model (Kyoto, Japan) which consists of pumps LC-
9A, Rheohydron injector and UV spectrophotometer detector
(SPD-6A) adjusted to the 256-nm wavelength. The column
was eluted with mobile phase methanol/H2O (50:50) and the
flow rate was adjusted to 1 ml/min. Then fractions of 1 ml
were collected separately using a fraction collector up to
20 ml and counted in a well-type γ-scintillation counter.

















Figure 2 HPLC radiochromatogram of 99mTc-histamine complex.
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The stability of 99mTc-histamine was studied in vitro by mixing
1.8 ml of normal human serum and 0.2 ml of 99mTc-histamine
and incubated at 37°C for (24 h). Exactly 0.2 ml aliquots were
withdrawn during the incubation at different time intervals
up to 6 h and subjected to paper chromatography for de-
termination of the percent of 99mTc-histamine, reduced
hydrolyzed technetium and free pertechnetate
Animal studies
The study was approved by the animal ethics committee,
Labeled Compound Department, and was in accordance
with the guidelines set out by the Egyptian Atomic Energy
Authority. Swiss Albino mice (25 to 30 g) were in-
travenously injected with 100 μl (100 to 150 MBq) of sterile






















Figure 3 Effect of Sn (II) amount on the labeling yield of 99mTc-histam
and 30 min. reaction time, n=3.vein and kept alive in metabolic cage for different intervals
of time under normal conditions. For quantitative determin-
ation of organ distribution, five mice were used for each ex-
periment and the mice were sacrificed at different times
post-injection. Samples of fresh blood, bone, and muscle
were collected in pre-weighed vials and counted. The differ-
ent organs were removed, counted, and compared to a
standard solution of the labeled histamine. The average per-
cent values of the administrated dose/organ were calculated.
Blood, bone, and muscles were assumed to be 7%, 10%, and
40%, respectively, of the total body weight (Motaleb 2001).
Corrections were made for background radiation and phy-
sical decay during experiment. Differences in the data were
evaluated with the Student's t test. Results for P using the
two-tailed test are reported and all the results are given as
mean ± SEM. The level of significance was set at P < 0.05.5 100 125 150
 % Labeled compound
 % Free99mTc 
 % Colloid
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ine, complex. Conditions: 3 mg histamine, 25-150 µg Sn (II), pH 4
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Figure 4 Effect of histamine amount on the labeling yield of 99mTc-histamine complex. Conditions: 1-10 mg of histamine, 50 µg Sn (II), pH 4
and 30 min. reaction time, n=3.
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The partition coefficient was determined by mixing 99mTc-
histamine with equal volumes of 1-octanol and phosphate
buffer (0.025 M at pH 7.4) in a centrifuge tube.
The mixture was vortexed at room temperature for
1 min and then centrifuged at 5,000 rpm for 5 min. Sub-
sequently, 100 μl samples from the 1-octanol and aqueous
layers were pipetted into other test tubes and counted
in a gamma counter. The measurement was repeated
five times. The partition coefficient value was expressed as
log p (Motaleb et al. 2011).
P ¼ Counts per min in octanole – Counts per min back ground
























Figure 5 Effect of pH of the reaction mixture of 99mTc-histamine com
reaction time, n=3.Results and discussion
Separation of 99mTc-histamine complex
In the case of the ascending paper chromatographic
method, acetone was used as the developing solvent; free
99mTcO4
− moved with the solvent front (Rf = 1), while
99mTc-histamine and reduced hydrolyzed technetium
remained at the point of spotting. In the case of the as-
cending paper chromatographic method, mixture was
used as the developing solvent; reduced hydrolyzed tech-
netium remains at the origin (Rf = 0), while other species
migrate with the solvent front (Rf = 1). The radiochem-
ical purity was determined by subtracting the sum of the
percent of reduced hydrolyzed technetium and free per-
technetate from 100%. The radiochemical yield is the
mean value of five experiments.4 5 6




plex. Conditions: 3 mg histamine, 50 µg Sn (II), pH 2-6 and 30 min.
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Figure 6 Effect of reaction time on the labeling yield of 99mTc-histamine complex. Conditions: 1-360 min. at optimum conditions, reaction
time, n=3.
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shows two peaks, one at fraction No. 4.4, which corres-
ponds to 99mTcO4
−, while the second peak was collected
at fraction No. 10.3 for 99mTc-histamine, which was found
to coincide with the UV signal.
Factors affecting labeling yield
Effect of SnCl2 · 2H2O amount
As shown in Figure 3, the radiochemical yield was de-
pendent on the amount of SnCl2 · 2H2O present in the
reaction mixture. At 25 μg SnCl2 · 2H2O, the labeling
yield of 99mTc-histamine was 81.6% due to the fact
that SnCl2 · 2H2O amount was insufficient to reduce allTable 1 Biodistribution of 99mTc-histamine in normal mice
Organs and body fluid % I.D./organ and body fluid at diffe
5 min 15 min
Liver 8.11 ± 0.3 6.2 ± 0.1
Urine 5.10 ± 0.2 8.60 ± 0.11
Kidneys 10.5 ± 0.1 12.25 ± 0.3
Blood 28.4 ± 0.5 24.8 ± 0.9
Heart 1.3 ± 0.01 1.40 ± 0.02
Lung 30.5 ± 0.2 12.8 ± 0.3
Intestine 3.50 ± 0.1 2.80 ± 0.2
Stomach 1.6 ± 0.06 1.20 ± 0.02
Spleen 1.6 ± 0.03 4.52 ± 0.21
Bone 1.90 ± 0.1 1.6 ± 0.3
Muscle 1.8 ± 0.01 1.6 ± 0.03
Brain 7.1 ± 0.12 4.85 ± 0.6
Thyroid 1.3 ± 0.05 0.9 ± 0.02
Brain/blood 0.25 0.2pertechnetate so the percentage of 99mTcO4
− was relatively
high (16.6%). The labeling yield significantly increased by
increasing the amount of SnCl2 · 2H2O from 25 to 50 μg
(optimum amount), at which a maximum labeling yield
of 98% was obtained. By increasing the amount of
SnCl2 · 2H2O above the optimum concentration value,
the labeling yield decreased again because the excess
SnCl2 · 2H2O was converted to colloid (50.6% at 150 μg
SnCl2 · 2H2O) (Liu et al. 2004).
Effect of histamine amount
The labeling yield of 99mTc-histamine complex was 55.5%
at 1 mg histamine and increased with increasing therent post-injection times
30 min 120 min 240 min
5.2 ± 0.2 3.2 ± 0.1 1.3 ± 0.02
18.1 ± 1.1 23.0 ± 2.3 31.5 ± 2.3
16.8 ± 1.2 15.2 ± 0.3 6.30 ± 22
6.1 ± 0.12 3.50 ± 0.1 1.2 ± 0.05
1.6 ± 0.01 0.9 ± 0.03 0.70 ± 0.02
11.30 ± 0.2 5.40 ± 0.10 3.25 ± 0.6
1.4 ± 0.02 1.2 ± 0.03 0.9 ± 0.02
2.2 ± 0.05 3.3 ± 0.13 3.70 ± 0.2
6.20 ± 0.2 5.3 ± 0.32 3.80 ± 0.16
2.0 ± 0.11 1.80 ± 0.30 1.70 ± 0.13
1.5 ± 0.01 1.2 ± 0.06 1.10 ± 0.02
1.4 ± 0.02 0.83 ± 0.06 0.62 ± 0.03
0.7 ± 0.03 0.55 ± 0.01 0.32 ± 0.01
0.23 0.24 0.52
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98% at 3 mg (Figure 4). The formed complex remained
stable with increasing the amount of histamine up to
10 mg. So the optimum amount of histamine was 3 mg
(Liu et al. 2004; Sanad 2007).
Effect of pH of the reaction mixture
As shown in Figure 5, at pH 2, the labeling yield of
99mTc-histamine complex was small and equal to 75.5%
and this yield increased with increasing the pH of the
reaction mixture where pH 4 gave the maximum label-
ing yield of 98%. By increasing the pH greater than 4,
the labeling yield decreased again till it became 55.5% at
pH 6 where colloid was the main impurity (35.2% at
pH 6) after pH 6 more colloidal solutions are formed
(Liu et al. 2004).
Effect of reaction time
Figure 6 describes the effect of incubation time on the
radiochemical purity of 99mTc-histamine complex. At
1 min post labeling, the yield was small and equal to
85.6% which increased with time till reaching its max-
imum value of 98% at 30 min. The yield remains stable
at 97.9% for a time up to 6 h (Liu et al. 2004).
Stability test
In vitro stability of 99mTc- histamine was studied in
order to determine the suitable time for injection to
avoid the formation of the undesired products that result
from the radiolysis of complex. These undesired radio-
active products might be accumulated in non-target
organs. The results of stability showed that the 99mTc-
histamine is stable up to 24 h and that at 37°C, resulted
in no release of radioactivity (n = five experiments) from
the 99mTc-histamine, as determined by paper chroma-
tography (Motaleb et al. 2011).
Partition coefficient for 99mTc- histamine
The partition coefficient values were 1.48 ± 0.02, showing
that the 99mTc-histamines are lipophilic and can cross the
blood–brain barrier.
Biodistribution of 99mTc-histamine
The biodistribution patterns of 99mTc-histamine is shown
in Table 1, the 99mTc-histamine was injected in normal
mice via intravenous route and was distributed all over
the body organs and fluids. All radioactivity levels are
expressed as average percent-injected dose per gram
(%ID/g ± SD). 99mTc-histamine was removed from the
circulation mainly through the kidneys and urine (ap-
proximately 37.8% injected dose at 2 h after injection of
the tracer). The liver uptake decreased markedly with time
for 99mTc-histamine from 8.11 ± 0.3, at 5 min till rea-
ching 1.3 ± 0.02 at 4 h (Sanad 2013; Motaleb et al. 2012).The high accumulation of 99mTc-histamine in lungs is de-
creased markedly with time from 30.5 ± 0.2, at 5 min till
reaching 3.5 ± 0.6 at 4 h (Suhara et al. 1998; Sanad and
Ibrahim 2013; Ibrahim and Sanad 2013; Sanad and El-
Tawoosy 2013). The biodistribution data showed substan-
tial uptake of 7.1 ± 0.12 (%ID/g ± SD) in the brain at 5 min
post-injection. After this time point, radioactivity dropped
to 4.85 ± 0.6 at 15 min post-injection. The maximum
brain uptake of 99mTc-histamine (7.1 ± 0.12) is higher than
that of currently used radiopharmaceuticals for brain
imaging, 99mTc-ethyl cysteinate dimer (99mTc-ECD) and
99mTc- hexamethylpropyleneamine oxime (99mTc-HMPAO)
which have maximum brain uptake of 4.7% and 2.25%, re-
spectively (Walovitch et al. 1989; Neirinckx et al. 1987);
therefore, 99mTc-histamine could be successfully used for
brain SPECT.Conclusion
Histamine can be labeled easily with 99mTc using 50 μg stan-
nous chloride dihydrate (SnCl2 · 2H2O) as a reducing agent
and 3 mg histamine at pH 4 for 30 min at room
temperature to give 99mTc-histamine complex with a radio-
chemical yield of 98%, which is higher than that of the com-
mercially available kit. Biodistribution studies showed that
the uptake of 99mTc-histamine in the brain (7.1% ± 0.12) is
higher than that of currently used radiopharmaceuticals for
brain imaging, 99mTc-ethyl cysteinate dimer (99mTc-ECD)
and 99mTc-hexamethylpropyleneamine oxime (99mTc-
HMPAO), respectively. 99mTc-histamine could be used for
brain SPECT. Furthermore, 99mTc histamine could be con-
sidered as a novel radiopharmaceutical for brain imaging.
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